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11:00 
~ Right Ventdculer Load Transcriptionally Activates 
the F1-ATP Synthese ~obunt t  In Vlvo and a 
Cis-Reglon of  Its Gene Is Inducible by Hypertrophic 
Stimuli In Cardlocytas " 
Tenenca X. O'Bden, Donald R. Menick, Mary S, Rackley, John D. Rozich, 
Paul J. McDermott, George Cooper W. VAMC & Medical University of South 
Carolina, Charleston, SC 
The mltochonddal F1-ATP synthase .8-sUbunlt (p-ATPese) is a key nuclear- 
encoded gene that must be precisely coordinated in oxidative phosphoryla- 
tion. Because of the hearra acute ATP requirements during hemod';namlc 
stress, and at least the initial ~.tnges of hear failure, 8-ATPase gene expres- 
sion was examined in an acute in vivo feline right ventdcular pressure over- 
load model and two in vitro models using neonatal rat cardiocytas timulated 
with either electrical pacing or phenyleph~'lne (PIE). ~-ATPase mRNA levels 
upregulatad rapidly, after 1 and 4 hr of acute load in vivo and by 2 hr reaching 
an equilfbdum between 12-I 8 hr with PE and 24-48 hr w~h electricaJ ~cin~. 
To investigate regulation, the polymerase chain reaction was used to isolate 
several gene fragments, including two -392 bp and -1522 t~ upstream of 
transcription initiation. P~ter subctot~ng into a lucltaresa repealer vector 
transiently co-trensf~cting with controls into neonatal rat cardiocyfas i;stng 
calcium phosphate precip~etton, these cells were atimulefed with PE or elec- 
trical pacing for 48 hr. l"~e -1522 construct demoeslratsd reporter activity 
which was inducible 20~/o by both PE and pacing, supporting the presence 
of important regulalonj c/s elements. The 392 bp promoter construct, which 
included elements known to be constitutively active in non-cardiac ells, was 
active but not indudbie, indicating a tack ot rote in cardiac inducibility. West- 
em blotting showed ,8-ATPase protein levels increasing pmpor~onata~/to 
lo~reeses in total protein. Therefore, the in vivo upregulalion of ,8-ATPasa to 
load is, In vitro to two disparate hypertrophic stimuli, at least portly transcrip- 
tlunal and includes the demonstration for the first time of inducibility of the 5' 
region. 
11:15 
~ Time-Dependent Changes in Gene ExpresMon in 
Myocytes From the Non-Infarcted Myoe, ardlum of  
Rats With Evolving Head Failure 
Ping Yue, Cadin S. Long, Paul C. Simpson, Wendy Hartogeesis, R 
David Foduln, Barry M. Massle, VAMC and Univ. of Ca, San Francia~, CA 
Fetal gane expression reemerges In pressure-ovedoed models of heart fail- 
ure, but less information is available in post-infamtion models. Therefore, 
we examined ,8 and aPmyosin heavy chains (MHC), skeletal ¢-astin (sACT) 
and sarcoplasmlc reticulum ATPase (SERCA2) mRNAs in myocytos isolated 
from the non-infarCted myocardium in rats t day, 1 wk and 6 wks following 
left coronary adery ligatlon (n = 6 for each time point) and sham-operated 
controls (n = 4 each). Only rats with large infarctions by ECG criteria and 
LVEDP > 15 mmHg were included. After hemodynamic measurements, mp 
ocytes were enzymatically isolated and cell volumes were determined using 
a Coulter muitisizer. RNA was extracted from LV myoaytes, and mRNA lev- 
els were determined by Northern and RNase protection assays. MI rats had 
hemodynamtc evidence of hear failure at each time ~lnt (elevated LVEDP 
and diminished P/dt) and significant LV myocyte hypertrophy at 6 wks (my- 
oayte volumes: 41.5 ± 0.9 vs 29.5 ± 2.6 x lIP pn~, p < 0.03). In rats 
with hear failure, compared to controls at the same time paint, sACT mRNA 
increased by 1.42, 1.53 and 134-fold at I day I wk and 6 wks, respeddvely 
(p = 0.05, < 0.05 and < 0.01). ,8-MHC mRNA was elevated at I and 6 wks 
(1,66 and 1.95 fold {p = 0.05 and < 0.01, respectively), and =-MHC message 
was 48% lower in heart failure rats at 6 wks (p < 0.001). SERCA2 mRNA was 
not affected at any time paint. Thus, dudng the remndgling procesa post-MI, 
changes in myocyte gene expression may occur as early as 24 hours. By 6 
wks, non-lnfarctad myocytes exhibit hypertrophy and changes in contractile 
protein expression similar to those observed in pressure-overload models 
of LVH and head failure. In contrast to the hypertrophy model I~owever, in 
past-infarction myocytes, SERCA2 expression is not repressed. 
11:30 
~ Beneficial Hemodynamle Actions of  Serectlve 
Endothelln-1 (Er.1) Blockade in Experimental Heart 
Failure 
Gordon W. Moe, Ana A~bomaz, Robert J, Howard, Duncan Stowed. 
University of Toronto, Toronto, ON, Canada 
Both plasma ET-1 and atrial netriuretio paptide (ANP) levels are elevated 
in hear failure (HF). To clarify the biologic role of endogenous ET-1 and its 
Interaction with ANP, we administered a specitlc ETA receptor alltagonigt 
FR-139137 (10 ug/kg/min IV for 45 minutes) to 7 dogs at baseline (B) and 
after induclion of HF by 4 weeks of rapid RV pacing. Data shown are 
and pcol~l SD (SDp) from ANOVA for HR (beats/mln); MAP (ram Fig); CO, 
(I/rain); systemic ~ ~ulmonic vascular resistance (SVR, PVR, units) at 
control (CTL) and 45 minutes of infusion (45 rain), at B and HE 
HR MAP CO SVR PVR 
B HF B HF B HF B HF B HF 
C]'l. 58 1471" 107 104 2.3 1.71" 45 5at 2,5 6.3 t 
45 min 76* 144 112 101 2,9" 2.1" 37* 43- 1,9" 4,7" 
SOp 9 25 18 11 0.5 0,4 11 9 0,7 1.5 
"p < O.OS w. CTL. tp < O.O5 vs. B 
HFwas assoclated with reduced CO and increased HR, SVR and PVR. FR- 
139137 increased CO and decreased SVR and PVR by similar propolons 
at B and HR HR was increased only at B. LV dp/dt and mean PA pressure 
were net changed by FR-139137 at B or HF. Plasma ANP (273 ± 88 at HF 
vs. 32 :~ 9 pg/ml at B, p < 0.01) and ET-1 levels (19 ± 4 at PIF vs. 12:1: 
3 p~ml at S, p < 0.05) were also not alts;ed by FR-139137 at B or HF, 
These data indicate that endogenous ET-1 conth'butes to the maintenance 
of SVR and PVR in normal condition and heightened SVR and PVR (n HE 
Fudhen~ore, our data do not support he role for the ETA receptor in the 
negative feedback regulation of ET-1 level and stimulation of ANP secretion 
in vivo in this model. 
11:45 
~ 11ssue Endothelin-1 lET-l) Profile in Experimental 
Heart Failure 
P. Cemasek, D J..Stewart, H. Gosselin, J. L. Rouleau. Me, Gill University, 
MontreN Heart It, ~ :itute, Montreal, QC; Universily of Toronto, St. Michae/~ 
Ho~o#al, T~onto ON, Canada 
Plasma levels of El-1 increase in severe heart failure (HF), however, little is 
known about local ~sue expression of ET-1 in the heart and other organs. 
We measured ET-I in the head, lung, k i~  and liver of 26 rats with vadous 
degrees of HF, 5 weeks after coronary ligation. The rats were divided ~n 3 
groups according to the size ol infarction scar. Gfl, < 55 mn~; Gdt, 90-130 
ram=; Gdif, > 160 mm 2. ET-t. Tissue levels were as follows (mean :E SEM, 
"p < 0.05): 
Gr (n) Vent. 
(Wing) 
C (7) 55 4-10 
I (111 544-10 
It ('~ 654- ~,,. 
Ul (8) 162 4-L"  
Atrial Pulm Corlex Pap~. 
(p~mg) (pg/mg pint) (p~'mg) (Wrng) 
N/D 29±2 0.74-11 2.1~0.1 
G :E0.1 97:1:2 0.6 ~0.1 5.5 :~ 0.7" 
" ]±0.05 31 :E2 0.6:t:0,1 5.9~0.6" 
i A-k 0.9" 51:t. 1" 1.14-0.1" 6.1~: 0.6" 
mean :i: SEM, "p ~ u.O5 
Compared with 7 control rats (G), ventfi~lar, atrial, pulmonary and renal 
cortical ET-1 was significantly increased on,'y in Gdll, whereas, in the renal 
papillae all 3 groups exhibited an increase. In contrasL them was no increase 
in the liver content of ET-1 in Gdll vs. C (196 ± 12 and t92 ± 8 fg/mg, map). 
Moreover, both ventdcutar and pulmonary ET-1 were significantly correlated 
w/th left vanti'/culer end diasto//c pm~sure (r : 0.65 and 0.74, rasp). We 
conclude that heart failure is associated with an increase in tissue levels 
of ET-1, in particular in the renal pa~'llae. Increases in ET-1 in the lung 
and ventricles In severe HF may contribute to ~)ulmonary hypertension or 
be involved in remodeling in response to the critical impairment of central 
he~dy.am~. 
Echocardiographic Investigations and Fetal 
Cardiology 
Tuesday, March 26, 1996, 10:30 a.m.-Noon 
Orange County Convention Center, Room 230B 
10:30 
~ T h e  Impact of Fatal Echocardiography on the 
Diagnosis of  Congenital Heart Defects: A 
Populctinn Based Study, Atlanta, 1990-1994 
Eduardo Montana, Muin Khoury, Kenneth Dooley, Shire Sham~, 
Pradip Dher, Janet Cregan, Kenneth Lynch, Derek Fyfe. Centers for 
Disease Centre/and Prevention and Fmory Univemi~ School of Medicine, 
At/ant& Georgia 
Them are few paputatior~based data on the current impact of fetal echecar- 
diography (FE) on the diagnosis, btrth prevalence rates, and overall survival 
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of congenital heart disease (CHD). To assess the impact of FE, we analyzed 
data from the Metropolitan Atlanta Congenital Defects Program (MACDP), 
a pppulation-based surveillance System for serious birth defects. Between 
January 1, 1990 and December 30, 1994, MACDP ascertained 1491 cases 
of CHD, for a birth prevalence of 8 per 1000 live births. In addition, we as- 
ceitelned FE-diagnosed congenital heart defects to residents of the same 
population. 
Of the 1491 cases of CHD, we found 70 cases where cardiac defects were 
diagnosed using FE (5%), FE diagnosis increased from less than 3% in 1990 
to almost 10% in 1993. In addition, the typos of heart defects diagnosed by 
FE varied considerably from the general birth population. Diagnoses us!ng 
FE were made on 23.1% of cases of Hypoplastio Left Heart Syndrome, 
15.1% of all Atrio-Vantricutar SeptsI DefeCtS, 13.1% of all cases of Tetralogy 
of Fallot, 6.5% of cases of Hypoplastic Right Heart Syndrome, and 5,P/a of 
all cases of Transposition of the Great Arteries, The death rata for livebom 
FE cases was 37.1% compared to 10.8% of infants diagnosed postnatally. 
Fetal demise was high among the prenatally diagnosed group with 10.0% 
being stillbsm, 
In conclusion, prenatally diagnosed cardiac defects are mere severe and 
have a poorer outcome than defects diagnosed postnatafly. FE will continue 
to have a profound impact on the practice of pediatric cardiology and the 
ability to conduct epidemiologic surveillance of cardiac defects in the popula- 
tion. 
10:45 
~6~ Etiology and Outcome of  Fetal Myoca|dial  Diseases 
Peter L. Ferrar, Thomas A. Quetel, Mad^'~en S. Mas, Fawwaz Selman, 
Maria Rcdriguez. University of Miami School of Medicine, Miami, FL 
The aim of this study was to evaluate our clinical experience with myocardial 
disease (MD) diagnosed in utere. Data from 860 patients (pts), 1374 fetal 
echooardiograms performed in our institution (1983-1995) were reviewed. 
Thirty one cases (3.6%) had MD, 
Echocardiographic data including chamber size, wall thickness, cardiac 
areas, parameters of systolic and diastolic function, were analyzed and 
compared tO 91 normal fetuses, according to their gastational age (GA). 
Postnatal echocardiographfc data and pathology, when available, was also 
reviewed. 
Results: 1) 24131 lots (81%) were fetuses of diabetic mothers with hy- 
pertrophic ardiomyopethy (HCMO) without outflow obstruction. HCMO was 
recognized between 31-38 wks GA, mean 34.5 wks. 6/24 pts (25%) had 
severe HCMO, congenital heart diseaSe (CHD) and hydrpps fetaiis (HI=). 
2) One fetus with HCMO had glycogen storage disease. 3) One fetus with 
HCMO had family history of HCMO. 4) Two fetuses had HCMO of unknown 
etiology. 5) One fetus with supraventricular tachycardia and HF, developed 
vsntricular arrhythmias postnatally; autopsy revealed onccoytic CMO. 6) One 
fetus had dilated CMO related to maternal hyperthyroidism, 7)One fetus had 
dilated CMO. and autopsy showed parvovirus myocardttis. Parameters of 
ventdcular function varied, the greater abnormalities were associated with 
cases with HF (10/31 pts, 32%). Six pls (31%) had severe arrhythmias. Death 
occurred in t0/31 pts (32%) (1 termination, 2 fetal demise, 7 posthatslly). 
Thus, myocardial diseases are rare in fetal cardiology practice. Its etiology 
is multiple, most frequently related to maternal diabetes. The association with 
CHD, arrhythmias or hydrops fetslis has a poor prognosis. Overall survival 
was 68%. 
11:00 
~'~ Maternal Administration of Indometha©in and 
Premature Constriction of the Ductus Arteriosua In 
the Human Fetus 
Kenji Harada, Takahiro Shlots, Masahiro Ishli, Mary J. Rice, 
Robert McDonald, David d. Sahn, Oregon Hith Sci Univ, Portland, OR 
Constriction of the fetal ductus arteflosus iDA) may occur during maternal 
therapy with indomethacin for premature labor. There is, however, little in- 
formation about the effect of gastational age (GA) or duration of therapy on 
the constriction of DA, A total 153 DOppler echocardiographic studies were 
performed on 69 women with 73 fetuses (65 singleton and 4 sets of twins) 
treated with indomethacin (100-150 rag/day) for premature labor. GA of the 
fetuses ranged form 21 to 31 weeks, As in previous reports, constriction of 
OJ, was defined as Doppler peak systolic velocity > 140 cm,'sec and diastolic 
flow velocity • 40 cm/sac. Constriction of DA occurred in 29 felusas (39%). 
No constriction was observed before 23 weeks of GA (Fig). The frequency of 
constriction of DA increased with geststionst age. Constriction of DA occurred 
within 5 days after starting indomelhecin in all. For fetuses < 25 weeks the 
constriction occurred after a mean of 3.1 -~ 1.1 day of indomethacin therapy 
for those > 26 weeks it occurred eadier, after only 1.6 ± 03 days (p < 0,001). 
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- I  Constriction of DA [ ]  
~t 4o 
lu  
o 
i t  ¢ l  == 21 I~ Im IT 111 11 lo = lw**u  
~UL 
Constriction of DA during maternal indomethacin administration for prema- 
ture labor is observed more commonly after 24 weeks of GA and its frequency 
increases wilh advancing age. For fetuses with advanced GA, even a short 
course of indomsthacin therapy may c~use DA constriction. 
11:15 
~Poor  Prognosis for  Fetuses With Restrictive 
Foremen OVals and Left Heart Obstructive Lesions:  
A Muitic~nter Study 
David J. Sahn, Mary J. Rice, Norman H. Siiverman, Achi Ludomirsky, Roger 
P. Vermilion, Lisa K. Homberger, Chadee Kleinman. Oregon Hlth Sci Univ, 
Portland, OR; U,'~iv Calif, San Francisco, CA; Mott Children's Hosp, Ann 
Arbor, MI; Boston Children's Hosp, Boston, MA; Yale Univ. New Haven, CT 
It has been regorted that restrictive foremen ovele (FOi n infants with hy- 
poplastfc felt heart syndrome (HLH) decreases the likelihood of success for 
cardiac transplant or Nonmood therapy options. We compared outcomes of 
17 fetuses diagnosed between 16-34 weeks of gestation with HLH and 9 
with cdflcal aortic stsnosis (AS) and dilated left ventricle; in all restriction of 
the FO was apparent. All fetuses had either a maximal size of the FO _ 2.5 
mm and/or continuous L --* R flow patterns with velocities > 60 era/see (up 
to 2.5 m/sac), or thickening of the atrial septum with no apparent flow. Three 
fetuses had large, tense L --* R bulging atrial septal aneurysms. Our.come: 
Three fetuses died in utero and 4 were electively terminated. Of the 14 with 
HLH that were born, 2 were not offered surgery and 4 died during attempted 
stabilization for Norwood surgery or transplant. Four of 6 died after Norwood 
surgery (preceded in 3 by emergency balloon anal eeptostomy), 1of the 2 
transplanted patients survived. Three of the 5 infants born with critical AS 
died, despite attempts to provide catheter or surgical vaivulotomy (4), or 
transplant (1). The total group yielded only 2 Norwood and one transplant 
HLH survivor and 2 critical AS survivors (I balloon, I surgical vaivuloplasty). 
The possibility of restricted FO should be specifically investigated on fetal 
eohas with severe left heart lesions and its' impact factored into decision- 
making. 
11:30 
~ Three-Dimensional Reconstruction of Color  Doppler  
Flow Images in Conge|l ital  Heart Disease 
Brian G. Sinclair, Gerald R. Marx, Takahiro Shiota, Natesa G. Pandian, 
David J. Sahn. Oregon Htth Sci Univ, Portland, OR; Tufts Mere, Boston, MA 
We used a 3D reconstruction system designed for viewing structural informa- 
tion for reconstructing in 3D, superimPOsed color Doppler flow maps of the 
flows related to regurgitant and/or stenotic lesions or septa| defects. Twenty- 
four patients (1 week-19 yrs) were imaged with an Interspec or VinpMed 
ultrasound system Interfaced with a Tomteo computer for 180 Q reta;ional 
transthorecic scan acquisitions. Studies were performed with and without 
color flow maps superimposed upon the 2D image. Since the 3D system 
does not cur~,'ntly have separate color pronessing, color maps were, ther~ 
fore, selected for discdminating flow, acceleration, allaslng and jets by gray 
scale. The best 3D images incorporating flow mapping were achieved from 
discrete, free or wall adherent valvular ogurgitant jets using relatively high 
Nyquist velocities wilh low color gain, Color Doppler Jet geometry, and ~D 
pmpagmion were well portrayed. Split or dual jets, flow convergences, ~,¢d 
jet-wall interactions were also visualized with unique pempoctivee. 3D flow 
streams and delineated flow orifices for VSD and ASD shunts provided a 
unique descriptor of defect size and shunt flow propagation. The addition of 
color Doppler flow mapping enhanced the 3D echo studies in most patients, 
and did not significantly increase acquisition or reconstruction time. At times, 
however, low velocity, bread diastolic inflows obscured tissue information dur- 
ing filling phases, A controller capable of allowing color overlay only during 
selected gated portions of the cardiac cycle is, therefore, being integrated 
into the system. Incorporating Doppler flow mapping into 3D imaging can 
enhance informalior: without compromising structural information and should 
expand the appllcab!!ity of3D methods in pediatric echocardiography. 
